232 related articles for article (PubMed ID: 14627879)
41. Simvastatin as an Adjunctive Therapy to Risperidone in Treatment of Autism: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Moazen-Zadeh E; Shirzad F; Karkhaneh-Yousefi MA; Khezri R; Mohammadi MR; Akhondzadeh S
J Child Adolesc Psychopharmacol; 2018 Feb; 28(1):82-89. PubMed ID: 28719227
[TBL] [Abstract][Full Text] [Related]
42. Galantamine efficacy and tolerability as an augmentative therapy in autistic children: A randomized, double-blind, placebo-controlled trial.
Ghaleiha A; Ghyasvand M; Mohammadi MR; Farokhnia M; Yadegari N; Tabrizi M; Hajiaghaee R; Yekehtaz H; Akhondzadeh S
J Psychopharmacol; 2014 Jul; 28(7):677-85. PubMed ID: 24132248
[TBL] [Abstract][Full Text] [Related]
43. Risperidone dosing in children and adolescents with autistic disorder: a double-blind, placebo-controlled study.
Kent JM; Kushner S; Ning X; Karcher K; Ness S; Aman M; Singh J; Hough D
J Autism Dev Disord; 2013 Aug; 43(8):1773-83. PubMed ID: 23212807
[TBL] [Abstract][Full Text] [Related]
44. Research knowledge among parents of children participating in a randomized clinical trial.
Vitiello B; Aman MG; Scahill L; McCracken JT; McDougle CJ; Tierney E; Davies M; Arnold LE
J Am Acad Child Adolesc Psychiatry; 2005 Feb; 44(2):145-9. PubMed ID: 15689727
[TBL] [Abstract][Full Text] [Related]
45. Risperidone improves behavioral symptoms in children with autism in a randomized, double-blind, placebo-controlled trial.
Pandina GJ; Bossie CA; Youssef E; Zhu Y; Dunbar F
J Autism Dev Disord; 2007 Feb; 37(2):367-73. PubMed ID: 17019624
[TBL] [Abstract][Full Text] [Related]
46. Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial.
Ghaleiha A; Asadabadi M; Mohammadi MR; Shahei M; Tabrizi M; Hajiaghaee R; Hassanzadeh E; Akhondzadeh S
Int J Neuropsychopharmacol; 2013 May; 16(4):783-9. PubMed ID: 22999292
[TBL] [Abstract][Full Text] [Related]
47. Palmitoylethanolamide as adjunctive therapy for autism: Efficacy and safety results from a randomized controlled trial.
Khalaj M; Saghazadeh A; Shirazi E; Shalbafan MR; Alavi K; Shooshtari MH; Laksari FY; Hosseini M; Mohammadi MR; Akhondzadeh S
J Psychiatr Res; 2018 Aug; 103():104-111. PubMed ID: 29807317
[TBL] [Abstract][Full Text] [Related]
48. A pilot double-blind placebo-controlled trial of pioglitazone as adjunctive treatment to risperidone: Effects on aberrant behavior in children with autism.
Ghaleiha A; Rasa SM; Nikoo M; Farokhnia M; Mohammadi MR; Akhondzadeh S
Psychiatry Res; 2015 Sep; 229(1-2):181-7. PubMed ID: 26208985
[TBL] [Abstract][Full Text] [Related]
49. Effects of risperidone on aberrant behavior in persons with developmental disabilities: II. Social validity measures.
McAdam DB; Zarcone JR; Hellings J; Napolitano DA; Schroeder SR
Am J Ment Retard; 2002 Jul; 107(4):261-9. PubMed ID: 12069645
[TBL] [Abstract][Full Text] [Related]
50. Minocycline as Adjunctive Treatment to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind Placebo-Controlled Trial.
Ghaleiha A; Alikhani R; Kazemi MR; Mohammadi MR; Mohammadinejad P; Zeinoddini A; Hamedi M; Shahriari M; Keshavarzi Z; Akhondzadeh S
J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):784-791. PubMed ID: 27128958
[TBL] [Abstract][Full Text] [Related]
51. A double-blind placebo controlled trial of piracetam added to risperidone in patients with autistic disorder.
Akhondzadeh S; Tajdar H; Mohammadi MR; Mohammadi M; Nouroozinejad GH; Shabstari OL; Ghelichnia HA
Child Psychiatry Hum Dev; 2008 Sep; 39(3):237-45. PubMed ID: 17929164
[TBL] [Abstract][Full Text] [Related]
52. Assessment in multisite randomized clinical trials of patients with autistic disorder: the Autism RUPP Network. Research Units on Pediatric Psychopharmacology.
Arnold LE; Aman MG; Martin A; Collier-Crespin A; Vitiello B; Tierney E; Asarnow R; Bell-Bradshaw F; Freeman BJ; Gates-Ulanet P; Klin A; McCracken JT; McDougle CJ; McGough JJ; Posey DJ; Scahill L; Swiezy NB; Ritz L; Volkmar F
J Autism Dev Disord; 2000 Apr; 30(2):99-111. PubMed ID: 10832774
[TBL] [Abstract][Full Text] [Related]
53. A randomized double blind placebo controlled clinical trial of N-Acetylcysteine added to risperidone for treating autistic disorders.
Ghanizadeh A; Moghimi-Sarani E
BMC Psychiatry; 2013 Jul; 13():196. PubMed ID: 23886027
[TBL] [Abstract][Full Text] [Related]
54. Brief Report: social disability in autism spectrum disorder: results from Research Units on Pediatric Psychopharmacology (RUPP) Autism Network trials.
Scahill L; Hallett V; Aman MG; McDougle CJ; Eugene Arnold L; McCracken JT; Tierney E; Deng Y; Dziura J; Vitiello B;
J Autism Dev Disord; 2013 Mar; 43(3):739-46. PubMed ID: 23104617
[TBL] [Abstract][Full Text] [Related]
55. Parent satisfaction in a multi-site acute trial of risperidone in children with autism: a social validity study.
Tierney E; Aman M; Stout D; Pappas K; Arnold LE; Vitiello B; Scahill L; McDougle C; McCracken J; Wheeler C; Martin A; Posey D; Shah B
Psychopharmacology (Berl); 2007 Mar; 191(1):149-57. PubMed ID: 17123125
[TBL] [Abstract][Full Text] [Related]
56. Psychopharmacology of aggression in children and adolescents with autism: a critical review of efficacy and tolerability.
Parikh MS; Kolevzon A; Hollander E
J Child Adolesc Psychopharmacol; 2008 Apr; 18(2):157-78. PubMed ID: 18439113
[TBL] [Abstract][Full Text] [Related]
57. The overt aggression scale for rating aggression in outpatient youth with autistic disorder: preliminary findings.
Hellings JA; Nickel EJ; Weckbaugh M; McCarter K; Mosier M; Schroeder SR
J Neuropsychiatry Clin Neurosci; 2005; 17(1):29-35. PubMed ID: 15746480
[TBL] [Abstract][Full Text] [Related]
58. Methodological issues in designing a multisite trial of risperidone in children and adolescents with autism.
Scahill L; McCracken J; McDougle CJ; Aman M; Arnold LE; Tierney E; Cronin P; Davies M; Ghuman J; Gonzalez N; Koenig K; Lindsay R; Martin A; McGough J; Posey DJ; Swiezy N; Volkmar F; Ritz L; Vitiello B
J Child Adolesc Psychopharmacol; 2001; 11(4):377-88. PubMed ID: 11838820
[TBL] [Abstract][Full Text] [Related]
59. Differential response of seven subjects with autistic disorder to clomipramine and desipramine.
Gordon CT; Rapoport JL; Hamburger SD; State RC; Mannheim GB
Am J Psychiatry; 1992 Mar; 149(3):363-6. PubMed ID: 1536276
[TBL] [Abstract][Full Text] [Related]
60. Participant satisfaction in a study of stimulant, parent training, and risperidone in children with severe physical aggression.
Rundberg-Rivera EV; Townsend LD; Schneider J; Farmer CA; Molina BB; Findling RL; Gadow KD; Bukstein OG; Arnold LE; Kolko DJ; Buchan-Page KA; McNamara NK; Michel C; Austin A; Kipp H; Rice RR; Aman MG
J Child Adolesc Psychopharmacol; 2015 Apr; 25(3):225-33. PubMed ID: 25885012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
